Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including kickbacks, billing fraud, ...
The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...
EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...
Scorpion Capital said in a newly-issued short report that in “20 years of shorting, TransMedics (TMDX) is the most extreme and grotesque ...
NDAQ:TMDX) Kehoe Law Firm, P.C. Securities Investigation on Behalf of Investors of TransMedics Group Stock Following Critical Report - NASDAQ: TMDX ...
TrafFix Devices, a leading manufacturer and supplier of traffic control devices and crash attenuation products, highlights the Scorpion II Blocker, a cutting-edge truck-mounted attenuator (TMA ...
TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...
As we look ahead to the new year, your support makes all the difference. Make a donation today to help us continue bringing science to life for millions of readers. And right now, your gift ...
The clear venom (left) and white venom (right) of a Tityus achilles, or an Achilles’ scorpion. Photos from ... a roughly 50-mile drive northwest from the capital city of Bogotá.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback